A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : IPMNs / intraductal papillary mucinous neoplasms

[Related PubMed/MEDLINE]
Total Number of Papers: 490
[Display Entries]
100 entries :
     (Publication year, Descending)
100 entries :
     (Publication year, Ascending)
>> all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   IPMNs  (>> Co-occurring Abbreviation)
Long Form:   intraductal papillary mucinous neoplasms
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
1  2020 Assessment of Malignancy Potential in Intraductal Papillary Mucinous Neoplasms of the Pancreas on MDCT. CI, HRS, ICG, NPV, OR, PPV, WFs
2  2020 Can the location of the mural nodule indicate benign or malignant in branch duct-type intraductal papillary mucinous neoplasm of the pancreas? BD, MD, MN, MN
3  2020 Circulating and Salivary Antibodies to Fusobacterium nucleatum Are Associated With Cystic Pancreatic Neoplasm Malignancy. ELISA, F. nucleatum, G. adiacens, HGD, S. gordonii
4  2020 Comparison of imaging modalities for measuring the diameter of intraductal papillary mucinous neoplasms of the pancreas. CT, EUS, LOA, MRI
5  2020 Diabetes and Weight Loss Are Associated With Malignancies in Patients With Intraductal Papillary Mucinous Neoplasms. OR
6  2020 Endosonographic diagnosis of advanced neoplasia in intraductal papillary mucinous neoplasms. ---
7  2020 Establishing a living biobank of patient-derived organoids of intraductal papillary mucinous neoplasms of the pancreas. PaCa, PDO
8  2020 EUS-guided confocal laser endomicroscopy: prediction of dysplasia in intraductal papillary mucinous neoplasms (with video). AUC, CI, HGD-Ca, IOA, LGD, nCLE
9  2020 Evolution of the immune landscape during progression of pancreatic intraductal papillary mucinous neoplasms to invasive cancer. ---
10  2020 Genomic characterization of malignant progression in neoplastic pancreatic cysts. MCNs
11  2020 GNAS mutation detection in circulating cell-free DNA is a specific predictor for intraductal papillary mucinous neoplasms of the pancreas, especially for intestinal subtype. cfDNA, PCNs
12  2020 Importance of each high-risk stigmata and worrisome features as a predictor of high-grade dysplasia in intraductal papillary mucinous neoplasms of the pancreas. HGD, HRS, LGD, OR
13  2020 Invasive Intraductal Papillary Mucinous Neoplasms: CT Features of Colloid Carcinoma Versus Tubular Adenocarcinoma of the Pancreas. MPD
14  2020 Long-term Risk of Malignancy in Branch-Duct Intraductal Papillary Mucinous Neoplasms. PDAC, SHRs
15  2020 Methylated DNA in Pancreatic Juice Distinguishes Patients With Pancreatic Cancer From Controls. HGD, MDMs, PDACs
16  2020 Methylation changes at the GNAS imprinted locus in pancreatic cystic neoplasms are important for the diagnosis of malignant cysts. GNAS, PCF, PDACs
17  2020 Mixed-type intraductal papillary mucinous neoplasm: Tailored surgical planning - case report. MRCP, MT
18  2020 Molecular characterization of organoids derived from pancreatic intraductal papillary mucinous neoplasms. ---
19  2020 Multilocular Cyst of Type 1 Autoimmune Pancreatitis Masquerading as Cancerization of Intraductal Papillary Mucinous Neoplasm. AIP
20  2020 Multimodal radiomics and cyst fluid inflammatory markers model to predict preoperative risk in intraductal papillary mucinous neoplasms. AUC, CFIM, CT, QI, TANs
21  2020 Multiphase computed tomography radiomics of pancreatic intraductal papillary mucinous neoplasms to predict malignancy. CT, ICG
22  2020 Multiregion whole-exome sequencing of intraductal papillary mucinous neoplasms reveals frequent somatic KLF4 mutations predominantly in low-grade regions. ---
23  2020 Mutational Mosaics of Cell-Free DNA from Pancreatic Cyst Fluids. cf, MCNs, PCFs, SCNs
24  2020 Noninvasive Discrimination of Low and High-risk Pancreatic Intraductal Papillary Mucinous Neoplasms. ---
25  2020 Paradoxical Role of AT-rich Interactive Domain 1A in Restraining Pancreatic Carcinogenesis. GEM, PDAC
26  2020 Prognosis of resected intraductal papillary mucinous neoplasm of the pancreas: using revised 2017 international consensus guidelines. CI, DSS, HR, RFS
27  2020 Psychological distress in patients under surveillance for intraductal papillary mucinous neoplasms of the pancreas: The "Sword of Damocles" effect calls for an integrated medical and psychological approach a prospective analysis. Brief-COPE, BSMSS, PSS
28  2020 Pylorus-Preserving Total Pancreatectomy for Intraductal Papillary Mucinous Neoplasm in the Setting of Previous Roux-en-Y Cystjejunostomy for Pancreatic Pseudocyst. ---
29  2020 Recurrent intraductal papillary mucinous neoplasms of the pancreas mimicking ampullary cancer. ---
30  2020 Role of volumetric multiparametric MRI in distinguishing between intraductal papillary mucinous neoplasms and serous cystadenoma. ADC, AUC, PCNs, ROI, SCAs, SI, vADC, vVE
31  2020 S6 ribosomal protein phosphorylation is associated with malignancy of intraductal papillary mucinous neoplasm of the pancreas. ---
32  2020 SATB2 in Neoplasms of Lung, Pancreatobiliary, and Gastrointestinal Origins. ADCAs, AMP, CCs, CRC, IHC, SATB2
33  2020 Serum Anti-p53 Antibody Can Serve as a Predictive Marker for Histological Grade of Intraductal Papillary Mucinous Neoplasms of the Pancreas. CA19-9, CEA, HGD, INV, S-p53 Ab
34  2020 Stratifying Intraductal Papillary Mucinous Neoplasms by Cyst Fluid Analysis: Present and Future. ---
35  2020 Surgical strategy forintraductal papillary mucinous neoplasms ofthepancreas. HGD, IPMC
36  2020 Survival Outcomes of Pancreatic Intraepithelial Neoplasm (PanIN) versus Intraductal Papillary Mucinous Neoplasm (IPMN) Associated Pancreatic Adenocarcinoma. IPMN, OS, PanIN, PanINs, PFS
37  2020 The Role of Positron Emission Tomography in Clinical Management of Intraductal Papillary Mucinous Neoplasms of the Pancreas. FDG, ICG, PET, PRISMA
38  2020 TSPO-targeted PET and Optical Probes for the Detection and Localization of Premalignant and Malignant Pancreatic Lesions. GEM, IGS, PanIN, TSPO
39  2020 Tuft Cells Inhibit Pancreatic Tumorigenesis in Mice by Producing Prostaglandin D2. PanIN, PDA
40  2020 Validation of Indications for Surgery of European Evidence-Based Guidelines for Patients with Pancreatic Intraductal Papillary Mucinous Neoplasms. DM, EEBGPCN, HGD, IC
41  2019 A Consensus Study of the Grading and Typing of Intraductal Papillary Mucinous Neoplasms of the Pancreas. ---
42  2019 Adjuvant chemotherapy is associated with improved postoperative survival in specific subtypes of invasive intraductal papillary mucinous neoplasms (IPMN) of the pancreas: it is time for randomized controlled data. DSS, IPMN
43  2019 Age-related morphological changes in the pancreas and their association with pancreatic carcinogenesis. PanIN, PDAC
44  2019 Benign Adrenocortical Tumors and the Detection of Nonadrenal Neoplasia. ---
45  2019 Blood Type as a Predictor of High-Grade Dysplasia and Associated Malignancy in Patients with Intraductal Papillary Mucinous Neoplasms. ---
46  2019 Characterization of Intraductal Papillary Neoplasm of the Bile Duct with Respect to the Histopathologic Similarities to Pancreatic Intraductal Papillary Mucinous Neoplasm. IPNBs
47  2019 Cyst Fluid Biosignature to Predict Intraductal Papillary Mucinous Neoplasms of the Pancreas with High Malignant Potential. ---
48  2019 Cyst location and presence of high grade dysplasia or invasive cancer in intraductal papillary mucinous neoplasms of the pancreas: a seven institution study from the central pancreas consortium. HGD, HRS, IC, WF
49  2019 Cytologic Analysis of Pancreatic Juice Increases Specificity of Detection of Malignant IPMN-A Systematic Review. AUC
50  2019 Determining Malignant Potential of Intraductal Papillary Mucinous Neoplasm of the Pancreas: CT versus MRI by Using Revised 2017 International Consensus Guidelines. IPMN
51  2019 Development of a stratification tool to identify pancreatic intraductal papillary mucinous neoplasms at lowest risk of progression. ---
52  2019 Endoscopic Ultrasound for Early Diagnosis of Pancreatic Cancer. CT, EUS, MRI
53  2019 Enrichment of oral microbiota in early cystic precursors to invasive pancreatic cancer. IL, PCN, PPI
54  2019 GNAS but Not Extended RAS Mutations Spectrum are Associated with a Better Prognosis in Intraductal Pancreatic Mucinous Neoplasms. EGFR
55  2019 Identification of Cystic Lesions by Secondary Screening of Familial Pancreatic Cancer (FPC) Kindreds Is Not Associated with the Stratified Risk of Cancer. BD, EUROPAC, FPC, IQR, PDAC
56  2019 Increased Risk of Second Primary Cancers Following Diagnosis of Malignant Intraductal Papillary Mucinous Neoplasms of the Pancreas: A Population-Based Study. CI, HRs, RR, SEER, SIR, SPCs
57  2019 Increased SOX9 Expression in Premalignant and Malignant Pancreatic Neoplasms. BP, HG, LG
58  2019 Integrated targeted metabolomic and lipidomic analysis: A novel approach to classifying early cystic precursors to invasive pancreatic cancer. HGD, LGD, PCNs, SCN
59  2019 Intraductal Papillary Mucinous Neoplasms Arise From Multiple Independent Clones, Each With Distinct Mutations. ---
60  2019 Main duct and mixed type intraductal papillary mucinous neoplasms without enhancing mural nodules: Duct diameter of less than 10 mm and segmental dilatation of main pancreatic duct are findings support surveillance rather than immediate surgery. CI, HGD, MD, MNs, MPD, OR
61  2019 Malignant conversion and peritoneal dissemination after endoscopic ultrasound-guided ethanol ablation in intraductal papillary mucinous neoplasm of the pancreas. EUS-PCA
62  2019 Management and outcomes of intraductal papillary mucinous neoplasms. BD, DSS, MD, MT, PDAC
63  2019 MRI Combined with Magnetic Resonance Cholangiopancreatography for Diagnosis of Benign and Malignant Pancreatic Intraductal Papillary Mucinous Neoplasms. MRCP, MRI
64  2019 Neutrophil to Lymphocyte Ratio is a Predictive Factor of Malignant Potential for Intraductal Papillary Mucinous Neoplasms of the pancreas. HGD, IGD, LGD, NLR, PNI
65  2019 Neutrophil-to-Lymphocyte Ratio as a Predictor of Invasive Carcinoma in Patients With Intraductal Papillary Mucinous Neoplasms of the Pancreas. NLR
66  2019 Obstructive cholangitis by mucus from an intraductal papillary mucinous neoplasm with pancreatobiliary fistula treated by endoscopic septotomy and direct peroral cholangioscopy: a case report. CT, ERCP
67  2019 Pathways of Progression From Intraductal Papillary Mucinous Neoplasm to Pancreatic Ductal Adenocarcinoma Based on Molecular Features. PDAs
68  2019 Pitfalls of histopathological evaluation of EUS-guided microbiopsies from pancreatic cystic neoplasms. SCNs
69  2019 Preoperative risk prediction for intraductal papillary mucinous neoplasms by quantitative CT image analysis. BD-IPMN
70  2019 Prevalence of Asymptomatic Intraductal Papillary Mucinous Neoplasms in Healthy and Ill Populations Detected by Ultrasonography: A Single-Center Study of 6353 Outpatients. HRS, OR, WF
71  2019 Prevalence of Germline Mutations Associated With Cancer Risk in Patients With Intraductal Papillary Mucinous Neoplasms. ---
72  2019 Single-cell sequencing defines genetic heterogeneity in pancreatic cancer precursor lesions. ---
73  2019 Single-Cell Transcriptomics of Pancreatic Cancer Precursors Demonstrates Epithelial and Microenvironmental Heterogeneity as an Early Event in Neoplastic Progression. HGD-IPMN, LGD-IPMNs, PDAC
74  2019 Subtyping of intraductal papillary mucinous neoplasms - pitfalls of MUC1 immunohistochemistry. PDAC
75  2019 Subtyping of IPMN. ---
76  2019 Talking Genes in Breast and Pancreatic Malignancies. FPC, PDAC
77  2019 Testing for Verification Bias in Reported Malignancy Risks for Side-Branch Intraductal Papillary Mucinous Neoplasms: A Simulation Modeling Approach. PDAC
78  2019 The Clinical Management of Main Duct Intraductal Papillary Mucinous Neoplasm of the Pancreas. MPD
79  2019 Usefulness of Deep Learning Analysis for the Diagnosis of Malignancy in Intraductal Papillary Mucinous Neoplasms of the Pancreas. AI, EUS
80  2019 What is the Outcome of Patients Affected by Intraductal Papillary Mucinous Neoplasms Without High-Risk Stigmata?: A Single-Center Retrospective Study. HRS
81  2018 A case of intraductal papillary-mucinous neoplasm of the pancreas penetrating into the stomach and spleen successfully treated by total pancreatectomy. CT, IPMC
82  2018 A Functional Spatial Analysis Platform for Discovery of Immunological Interactions Predictive of Low-Grade to High-Grade Transition of Pancreatic Intraductal Papillary Mucinous Neoplasms. PDAC
83  2018 Are pancreatic IPMN volumes measured on MRI images more reproducible than diameters? An assessment in a large single-institution cohort. ICCs, LOA
84  2018 ARID1A Maintains Differentiation of Pancreatic Ductal Cells and Inhibits Development of Pancreatic Ductal Adenocarcinoma inMice. ATP, PanINs, PDACs, PDCs
85  2018 Cells of origin of pancreatic neoplasms. MCNs, PanINs, PDAC
86  2018 Clinical and Radiographic Gastrointestinal Abnormalities in McCune-Albright Syndrome. GI, MAS, MRCP
87  2018 Conditional survival analysis for patients with intraductal papillary mucinous neoplasms (IPMNs) undergoing curative resection. CS, MD, PD, SEER, UD, WD
88  2018 CT radiomics to predict high-risk intraductal papillary mucinous neoplasms of the pancreas. AUC, BD
89  2018 Curative resection of pancreatic ductal adenocarcinoma developing in the remnant pancreas 13 years after distal pancreatectomy for intraductal papillary mucinous neoplasms: A case report. PDAC
90  2018 Cyst Fluid Biomarkers - Diagnosis and Prediction of Malignancy for Cystic Lesions of the Pancreas. MCNs
91  2018 Development and Validation of a Multi-institutional Preoperative Nomogram for Predicting Grade of Dysplasia in Intraductal Papillary Mucinous Neoplasms (IPMNs) of the Pancreas: A Report from The Pancreatic Surgery Consortium. BD
92  2018 Does Surgical Margin Impact Recurrence in Noninvasive Intraductal Papillary Mucinous Neoplasms?: A Multi-institutional Study. ---
93  2018 Evaluation of the International Consensus Guidelines for the Surgical Resection of Intraductal Papillary Mucinous Neoplasms. MPD
94  2018 GNASR201C Induces Pancreatic Cystic Neoplasms in Mice That Express Activated KRAS by Inhibiting YAP1 Signaling. PDACs, YAP
95  2018 Identification of a pyruvate-to-lactate signature in pancreatic intraductal papillary mucinous neoplasms. HGD, IHC, LGD
96  2018 Imaging Follow-up of Low-Risk Incidental Pancreas and Kidney Findings: Effects of Patient Age and Comorbidity on Projected Life Expectancy. LE, SB
97  2018 Improved Detection of Circulating Epithelial Cells in Patients with Intraductal Papillary Mucinous Neoplasms. CECs
98  2018 Intraductal Papillary Mucinous Neoplasm of the Pancreas in Young Patients: Tumor Biology, Clinical Features, and Survival Outcomes. ---
99  2018 Intraductal papillary mucinous neoplasms of the pancreas: a clinical challenge. ---
100  2018 Intraductal Papillary Mucinous Neoplasms of the Pancreas: Current Understanding and Future Directions for Stratification of Malignancy Risk. ---